Trial reportClinical transplantation
Metabolic syndrome and new onset diabetes after transplantation in kidney transplant recipients.
Trial report in Clinical transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04489043 (Exercise, Prediabetes and Diabetes After Renal Transplantation.), which is not on this map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Exercise, Prediabetes and Diabetes After Renal Transplantation.
Who cites it
20 citing papers in PubMed, 43 citations in OpenAlex.
- Early basal insulin therapy decreases new-onset diabetes after renal transplantation.Journal of the American Society of Nephrology : JASN · 2012Trial
- The Association Between Variability in Tacrolimus Trough Levels and Posttransplant Diabetes Mellitus in Thai Kidney Transplant Patients.Transplantation direct · 2026Article
- Metabolic dysregulation and antibody-mediated rejection after kidney transplantation: interacting mechanisms and emerging clinical strategies.Frontiers in immunology · 2026Review
- Post-transplant diabetes mellitus after kidney transplantation: pathogenesis, risk factors, and management strategies.Frontiers in endocrinology · 2026Review
- GLP-1 and glucagon receptor dual agonism ameliorates kidney allograft fibrosis by improving lipid metabolism.Frontiers in immunology · 2025Article
- Exercise and Prediabetes After Renal Transplantation (EXPRED-I): A Prospective Study.Sports medicine - open · 2023Article
- Indoxyl Sulphate Retention Is Associated with Microvascular Endothelial Dysfunction after Kidney Transplantation.International journal of molecular sciences · 2023Article
- Obesity Management in Kidney Transplant Candidates: Current Paradigms and Gaps in Knowledge.Advances in chronic kidney disease · 2021Review
- Associations between High Serum Adipocyte Fatty Acid Binding Protein and First Hospitalization in Kidney Transplantation Patients: A 5-Year Follow-up Study.International journal of environmental research and public health · 2020Article
- Comparison of post-transplantation diabetes mellitus incidence and risk factors between kidney and liver transplantation patients.PloS one · 2020Article
- Feasibility and acceptability of a televideo physical activity and nutrition program for recent kidney transplant recipients.Pilot and feasibility studies · 2020Article
- HbA1c levels at 90 days after renal transplantation in non-diabetic recipients predict de novo pre-diabetes and diabetes at 1 and 3 years after transplantation.International urology and nephrology · 2018Article
- Cardiovascular effects of metabolic syndrome after transplantation: convergence of obesity and transplant-related factors.Clinical kidney journal · 2018Article
- Circulating Haptoglobin and Metabolic Syndrome in Renal Transplant Recipients.Scientific reports · 2017Article
- Positive correlation of serum adipocyte fatty acid binding protein levels with metabolic syndrome in kidney transplantation patients.International journal of clinical and experimental pathology · 2017Article
- Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients.PloS one · 2015Article
- Influencing factors of new-onset diabetes after a renal transplant and their effects on complications and survival rate.PloS one · 2014Article
- Metabolic syndrome in hemodialysis patients as a risk factor for new-onset diabetes mellitus after renal transplant: a prospective observational study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2013Article
- Metabolic syndrome, vitamin D deficiency and hypoadiponectinemia among nondiabetic patients early after kidney transplantation.American journal of nephrology · 2013Article
- Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP).American journal of kidney diseases : the official journal of the National Kidney Foundation · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
backgroundMetabolic syndrome (MS) and new onset diabetes after transplant (NODAT) are common in kidney transplant patients. We studied the relationship between the two conditions and their impact on metabolic and cardiovascular risk profiles.
methodsAll non-diabetic patients transplanted between 1999 and 2005 who were followed up to 2006 were included. MS and NODAT were determined. Kaplan-Meier survival and various regression analyses were performed to determine the clinical correlates for both conditions and their association with various cardiovascular risk factors.
resultsAmong 591 patients, 314 (53.1%) had MS and 90 (15.2%) developed NODAT. The two conditions were highly associated with each other as 84 patients with NODAT also had MS (14.2%). Elevated body mass index and fasting glucose levels at transplant were risk factors for both conditions, whereas weight gain after transplant was associated only with MS. African American, old age, and hypertension-related ESRD were risk factors for NODAT. Finally, the presence of MS was associated with reduced kidney function and elevated uric acid levels, whereas the presence of NODAT with elevated pulse pressure.
conclusionsMS and NODAT are highly prevalent and significantly associated with impaired metabolic and cardiovascular risk profiles. Early identification of such conditions may facilitate targeted therapeutic intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.